Key statistics
On Thursday, Biontech SE (BNTXN:MEX) closed at 2,099.00, -17.69% below its 52-week high of 2,550.00, set on Jan 29, 2025.
52-week range
Open | 2,099.00 |
---|---|
High | 2,099.00 |
Low | 2,099.00 |
Bid | -- |
Offer | 2,400.00 |
Previous close | 2,099.00 |
Average volume | 51.50 |
---|---|
Shares outstanding | 240.39m |
Free float | 214.95m |
P/E (TTM) | -- |
Market cap | 27.14bn USD |
EPS (TTM) | -3.72 USD |
Data delayed at least 20 minutes, as of Jul 10 2025 14:05 BST.
More ▼
- EQS-News: GENUI sells labor team to Galenica
- EQS-News: Mallia Innovations: Mallia Appoints Jens Holstein, Dr. Alexandra Ogilvie, and Dr. Ulrich Dauer to its Advisory Board
- EQS-News: MIG Capital Announces €50 Million in Series A Funding for Look Up
- BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
- BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
- EQS-News: Mallia sets strategic course for future and completes €5.5 million financing
- BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
- BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
- BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline
- BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
More ▼